Understanding Hypocomplementemic Urticarial Vasculitis (HUVS)
At a Glance
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare immune condition affecting small blood vessels. Its hives-like spots often last longer than 24 hours, feel painful or burning, can leave dark marks, and may involve the joints, eyes, kidneys, or lungs.
If you have spent months or even years visiting doctors for “hives” that don’t act like normal hives, receiving a diagnosis of Hypocomplementemic Urticarial Vasculitis Syndrome (HUVS) can be both a relief and a source of new questions. Also known as McDuffie syndrome, this condition is exceptionally rare [1]. Because most local clinicians may only see one case in their entire career, your journey to this diagnosis often involves many specialists and repeated tests [2]. Before confirming HUVS, your clinician will perform a broader exclusion workup to ensure your symptoms are not caused by medications, infections, cryoglobulinemia, or other systemic vasculitides.
HUVS is more than just a skin condition; it is a systemic (body-wide) vasculitis, which means inflammation of the blood vessels [3]. Unlike common hives (urticaria), which are usually an allergic reaction, HUVS is driven by the immune system attacking the body’s own small blood vessels [4].
Why HUVS is Different from “Normal” Hives
The skin lesions in HUVS are called wheals. While they look like hives, they behave differently in several key ways:
- Duration: Normal hives usually fade within 24 hours. In HUVS, individual wheals often stay in the same spot for more than 24 hours [5][6].
- Sensation: While hives are typically itchy, HUVS lesions are more likely to feel painful, burning, or tender [7][6].
- After-effects: As the inflammation resolves, HUVS lesions may leave behind a bruise-like mark or a brownish stain, known as postinflammatory hyperpigmentation [5][8].
The Role of the Complement System
To understand the “Hypocomplementemic” part of the name, you have to look at your complement system. This is a group of proteins in your blood that acts like a “helper” to your immune system, helping it identify and “complement” the destruction of germs [4].
In HUVS, this system becomes overactive and turns against the body. This happens through a process involving immune complexes—clumps formed when your antibodies lock onto certain proteins [4]. These clumps settle in the walls of your small blood vessels.
- Consumption: Because the complement system is constantly active to clear these clumps, it uses up its protein supply faster than the body can make it. This results in hypocomplementemia (low levels of complement proteins like C1q, C3, and C4 in your blood) [9][7].
- Recruitment: The activation of these proteins sends out a chemical “flare” that recruits neutrophils (a type of white blood cell).
- Damage: These white blood cells release powerful enzymes to address the clumps, but because the clumps are stuck to your blood vessels, the enzymes cause inflammation and damage the vessel walls instead [4][10].
Understanding the Anti-C1q Antibody
A hallmark of HUVS is often the presence of anti-C1q antibodies [11]. These are specific antibodies that target C1q, one of the very first proteins in the complement “trigger” sequence [2].
- Depending on the study and assay used, about half of patients with HUVS will test positive for these antibodies [2].
- Having low levels of C1q itself may support the diagnosis, but neither anti-C1q nor low C1q alone establishes the diagnosis [2].
- These antibodies are not unique to HUVS; they can also be found in other conditions like Systemic Lupus Erythematosus (SLE) [11][12].
How Rare is HUVS?
HUVS is considered a very rare disease. While exact global numbers are hard to pin down because it is often misdiagnosed, a study in Sweden estimated that only about 0.7 people per million are diagnosed with it each year [13]. For perspective, that makes it significantly rarer than many other autoimmune diseases.
Beyond the Skin: Systemic Involvement
While the skin is usually the first place symptoms appear, the inflammation in HUVS can affect other parts of the body where small blood vessels are prominent [2]:
- Joints: Many patients experience arthritis (joint inflammation) or arthralgia (joint pain) [13][7].
- Eyes: Inflammation can occur in the eyes (uveitis or episcleritis), causing redness or pain [14][13].
- Kidneys and Lungs: In some cases, the clumps can settle in the filters of the kidneys or the small vessels of the lungs, making monitoring of these organs a standard part of long-term care [3][15].
Confirming the Diagnosis
Because HUVS can look like other conditions, doctors typically use a “major and minor” criteria system (such as the Schwartz criteria) [14].
- Major Criteria: Chronic hives for at least 6 months and low complement levels [14].
- Minor Criteria: These include evidence of vasculitis on a skin biopsy (looking for leukocytoclasis, which is the debris of white blood cells), joint pain, eye inflammation, kidney involvement, and the presence of anti-C1q antibodies [14][16][17].
A skin biopsy is often the “gold standard” for moving from a diagnosis of simple hives to urticarial vasculitis [17]. It allows a pathologist to see the actual damage to the blood vessel walls under a microscope [6].
Common questions in this guide
How can I tell HUVS hives from ordinary hives?
What do low C1q, C3, and C4 levels mean in HUVS?
Does a positive anti-C1q antibody test confirm HUVS?
What tests are used to diagnose hypocomplementemic urticarial vasculitis?
What can a skin biopsy show in HUVS?
Can HUVS affect organs beyond the skin?
How rare is HUVS?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which specific diagnostic criteria (such as the Schwartz or Jennekens criteria) were used to confirm my diagnosis?
- 2.What did my skin biopsy show regarding leukocytoclasis or fibrin deposits in the blood vessels?
- 3.Are my current C1q, C3, and C4 levels low, and how often should we monitor these markers to track disease activity?
- 4.Do I have anti-C1q antibodies, and how does that result influence my treatment plan or prognosis?
- 5.Based on my tests, are there any signs that my kidneys, lungs, or other organs are involved?
- 6.Does my presentation overlap with systemic lupus erythematosus (SLE), and how will you distinguish between the two over time?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Kidney Involvement in Hypocomplementemic Urticarial Vasculitis Syndrome-A Case-Based Review.
Ion O, Obrișcă B, Ismail G, et al.
Journal of clinical medicine 2020; (9(7)) doi:10.3390/jcm9072131.
PMID: 32640739 - 2
[Hypocomplementemic urticarial vasculitis].
Jachiet M, Flageul B, Bouaziz JD, et al.
La Revue de medecine interne 2018; (39(2)):90-98 doi:10.1016/j.revmed.2017.03.005.
PMID: 28457680 - 3
[Renal manifestations in vasculitides of small and medium-sized vessels].
Schneider J, Venhoff N
Zeitschrift fur Rheumatologie 2022; (81(10)):851-857 doi:10.1007/s00393-022-01282-6.
PMID: 36331616 - 4
Case Report: Hypocomplementemic urticarial vasculitis syndrome in a pediatric patient with complement factor 1 deficiency.
Lin S, Kafisheh D, Elder ME
Frontiers in pediatrics 2024; (12()):1448094 doi:10.3389/fped.2024.1448094.
PMID: 39376673 - 5
Urticarial Vasculitis Differs From Chronic Spontaneous Urticaria in Time to Diagnosis, Clinical Presentation, and Need for Anti-Inflammatory Treatment: An International Prospective UCARE Study.
Bonnekoh H, Jelden-Thurm J, Allenova A, et al.
The journal of allergy and clinical immunology. In practice 2023; (11(9)):2900-2910.e21 doi:10.1016/j.jaip.2023.06.030.
PMID: 37364667 - 6
Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey.
Krause K, Bonnekoh H, Jelden-Thurm J, et al.
Clinical and translational allergy 2023; (13(10)):e12305 doi:10.1002/clt2.12305.
PMID: 37876033 - 7
Clinical Profile of Patients with Urticarial Vasculitis in China: A Retrospective of 142 Cases.
Hu W, Zhu Y, Geng S, et al.
Journal of inflammation research 2026; (19()):576374 doi:10.2147/JIR.S576374.
PMID: 41877830 - 8
Mimickers of Urticaria: Urticarial Vasculitis and Autoinflammatory Diseases.
Davis MDP, van der Hilst JCH
The journal of allergy and clinical immunology. In practice 2018; (6(4)):1162-1170 doi:10.1016/j.jaip.2018.05.006.
PMID: 29871797 - 9
Correct approach in urticarial vasculitis made early diagnosis of lupus nephritis possible: a case report.
Smets K, Van Baelen A, Sprangers B, De Haes P
Journal of medical case reports 2022; (16(1)):314 doi:10.1186/s13256-022-03477-6.
PMID: 35989318 - 10
[Update on etiopathogenesis of small vessel vasculitis].
Arnold S, Holl-Ulrich K, Müller A, et al.
Zeitschrift fur Rheumatologie 2022; (81(4)):270-279 doi:10.1007/s00393-021-01155-4.
PMID: 35084556 - 11
Analysis of Anti-C1q Autoantibodies by Western Blot.
Verlemyr A, Truedsson L, Skattum L
Methods in molecular biology (Clifton, N.J.) 2019; (1901()):183-189 doi:10.1007/978-1-4939-8949-2_14.
PMID: 30539577 - 12
Clinical utility of anti-C1q antibody in primary and secondary vasculitic conditions.
Jayakanthan K, Gupta AN, Mathew J, et al.
International journal of health sciences 2017; (11(5)):3-6.
PMID: 29114186 - 13
Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis).
Sjöwall C, Mandl T, Skattum L, et al.
Rheumatology (Oxford, England) 2018; (57(8)):1400-1407 doi:10.1093/rheumatology/key110.
PMID: 29718374 - 14
Urticarial hypocomplementemic vasculitis syndrome and systemic lupus erythematosus: a case report and review of the literature.
Ouerdani Y, Ben Achour T, Ben Hmid A, et al.
Frontiers in immunology 2025; (16()):1649699 doi:10.3389/fimmu.2025.1649699.
PMID: 40852710 - 15
Hypocomplementemic Urticarial Vasculitis Syndrome or Systemic Lupus Erythematosus in Evolution?
Kesarwani V, Phachu D, Trivedi R
Cureus 2022; (14(3)):e23429 doi:10.7759/cureus.23429.
PMID: 35481300 - 16
Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis.
Marzano AV, Maronese CA, Genovese G, et al.
The Journal of allergy and clinical immunology 2022; (149(4)):1137-1149 doi:10.1016/j.jaci.2022.02.007.
PMID: 35396080 - 17
A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria.
Puhl V, Bonnekoh H, Scheffel J, et al.
Clinical and translational allergy 2021; (11(2)):e12031 doi:10.1002/clt2.12031.
PMID: 33949135
This page about HUVS is for informational purposes only and does not constitute medical advice. Your clinician and specialists should interpret your complement tests, skin biopsy, and organ evaluations for your individual care.
Get notified when new evidence is published on Hypocomplementemic urticarial vasculitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.